Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cardiovascular Protection in the Treatment of Type 2 Diabetes: A Review of Clinical Trial Results Across Drug Classes
Francesco Paneni, Thomas F. Lüscher
The American Journal of Medicine (2017) Vol. 130, Iss. 6, pp. S18-S29
Open Access | Times Cited: 97

Showing 1-25 of 97 citing articles:

Cardiomyopathy in obesity, insulin resistance and diabetes
Michinari Nakamura, Junichi Sadoshima
The Journal of Physiology (2019) Vol. 598, Iss. 14, pp. 2977-2993
Open Access | Times Cited: 219
Metformin limits osteoarthritis development and progression through activation of AMPK signalling
Jun Li, Bin Zhang, Wei‐Xiao Liu, et al.
Annals of the Rheumatic Diseases (2020) Vol. 79, Iss. 5, pp. 635-645
Open Access | Times Cited: 209
Metformin: An Old Drug with New Applications
Joseph Zhou, Scott Massey, Darren Story, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 10, pp. 2863-2863
Open Access | Times Cited: 204
Insulin: too much of a good thing is bad
Hubert Kolb, Kerstin Kempf, Martin Röhling, et al.
BMC Medicine (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 174
Cardiovascular disease in diabetes, beyond glucose
Robert H. Eckel, Karin Bornfeldt, Ira J. Goldberg
Cell Metabolism (2021) Vol. 33, Iss. 8, pp. 1519-1545
Open Access | Times Cited: 136
Vascular ageing: moving from bench towards bedside
Rachel E. Climie, Jordi Alastruey, Christopher Mayer, et al.
European Journal of Preventive Cardiology (2023) Vol. 30, Iss. 11, pp. 1101-1117
Open Access | Times Cited: 67
Impact of Glycemic Variability on Chromatin Remodeling, Oxidative Stress, and Endothelial Dysfunction in Patients With Type 2 Diabetes and With Target HbA1c Levels
Sarah Costantino, Francesco Paneni, Rodolfo Battista, et al.
Diabetes (2017) Vol. 66, Iss. 9, pp. 2472-2482
Open Access | Times Cited: 163
Advanced Glycation End Products: Potential Mechanism and Therapeutic Target in Cardiovascular Complications under Diabetes
Ping Yang, Jian Feng, Qing Peng, et al.
Oxidative Medicine and Cellular Longevity (2019) Vol. 2019, pp. 1-12
Open Access | Times Cited: 120
The Vasculature in Prediabetes
David H. Wasserman, Thomas J. Wang, Nancy J. Brown
Circulation Research (2018) Vol. 122, Iss. 8, pp. 1135-1150
Open Access | Times Cited: 115
Ertugliflozin Compared with Glimepiride in Patients with Type 2 Diabetes Mellitus Inadequately Controlled on Metformin: The VERTIS SU Randomized Study
Priscilla Hollander, Jie Liu, Julie Hill, et al.
Diabetes Therapy (2017) Vol. 9, Iss. 1, pp. 193-207
Open Access | Times Cited: 101
Pharmacologic Management of Type 2 Diabetes Mellitus: Available Therapies
James Thrasher
The American Journal of Cardiology (2017) Vol. 120, Iss. 1, pp. S4-S16
Open Access | Times Cited: 99
Triglyceride glucose and haemoglobin glycation index for predicting outcomes in diabetes patients with new-onset, stable coronary artery disease: a nested case-control study
Jing‐Lu Jin, Di Sun, Ye‐Xuan Cao, et al.
Annals of Medicine (2018) Vol. 50, Iss. 7, pp. 576-586
Closed Access | Times Cited: 98
A high triglyceride glucose index is more closely associated with hypertension than lipid or glycemic parameters in elderly individuals: a cross-sectional survey from the Reaction Study
Binruo Zhu, Jie Wang, Kang Chen, et al.
Cardiovascular Diabetology (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 88
Cardiovascular Protection by Sodium Glucose Cotransporter 2 Inhibitors: Potential Mechanisms
Bart Staels
The American Journal of Medicine (2017) Vol. 130, Iss. 6, pp. S30-S39
Open Access | Times Cited: 87
MALAT1 as a Diagnostic and Therapeutic Target in Diabetes-Related Complications: A Promising Long-Noncoding RNA
Leila Elmi Abdulle, Ji‐Long Hao, Om Prakash Pant, et al.
International Journal of Medical Sciences (2019) Vol. 16, Iss. 4, pp. 548-555
Open Access | Times Cited: 86
Are the cardiovascular and kidney benefits of empagliflozin influenced by baseline glucose‐lowering therapy?
Silvio E. Inzucchi, David Fitchett, Dubravka Jurišić‐Eržen, et al.
Diabetes Obesity and Metabolism (2019) Vol. 22, Iss. 4, pp. 631-639
Closed Access | Times Cited: 77
The SGLT2 Inhibitor Luseogliflozin Rapidly Normalizes Aortic mRNA Levels of Inflammation-Related but Not Lipid-Metabolism-Related Genes and Suppresses Atherosclerosis in Diabetic ApoE KO Mice
Yusuke Nakatsu, Hiroki Kokubo, Bumdelger Batmunkh, et al.
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 8, pp. 1704-1704
Open Access | Times Cited: 78
Liraglutide repairs the infarcted heart: The role of the SIRT1/Parkin/mitophagy pathway
Huiying Qiao, Haiyan Ren, He Du, et al.
Molecular Medicine Reports (2018)
Open Access | Times Cited: 78
A Clinical Review of Diabetic Foot Infections
Cody A. Chastain, Nathan Klopfenstein, C. Henrique Serezani, et al.
Clinics in Podiatric Medicine and Surgery (2019) Vol. 36, Iss. 3, pp. 381-395
Closed Access | Times Cited: 57
Metformin attenuates osteoclast-mediated abnormal subchondral bone remodeling and alleviates osteoarthritis via AMPK/NF-κB/ERK signaling pathway
Haohui Guo, Dong Ding, Limei Wang, et al.
PLoS ONE (2021) Vol. 16, Iss. 12, pp. e0261127-e0261127
Open Access | Times Cited: 42
Advanced glycation end product signaling and metabolic complications: Dietary approach
Mohammad Idreesh Khan, Fauzia Ashfaq, Abdulrahman A. Alsayegh, et al.
World Journal of Diabetes (2023) Vol. 14, Iss. 7, pp. 995-1012
Open Access | Times Cited: 20
Cardiovascular Protection by Sodium Glucose Cotransporter 2 Inhibitors: Potential Mechanisms
Bart Staels
The American Journal of Cardiology (2017) Vol. 120, Iss. 1, pp. S28-S36
Open Access | Times Cited: 57
Cardiovascular outcome studies in type 2 diabetes: Comparison between SGLT2 inhibitors and GLP-1 receptor agonists
André Scheen
Diabetes Research and Clinical Practice (2018) Vol. 143, pp. 88-100
Closed Access | Times Cited: 55
Mortality and cardiovascular disease burden of uncontrolled diabetes in a registry-based cohort: the ESCARVAL-risk study
Jorge Navarro-Pérez, Domingo Orozco‐Beltrán, Vicente Gil-Guillén, et al.
BMC Cardiovascular Disorders (2018) Vol. 18, Iss. 1
Open Access | Times Cited: 51
LncRNA MALAT1 promotes high glucose-induced inflammatory response of microglial cells via provoking MyD88/IRAK1/TRAF6 signaling
Liqing Wang, Hengjun Zhou
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 50
Page 1 - Next Page

Scroll to top